Price Alert

Elanco Animal Health (ELAN)

NYSE: ELAN · Real-Time Price · USD

18.05

0.05 (0.28%)

At close: Aug 15, 2025, 9:59 AM

Elanco Animal Health Statistics

Share Statistics

Elanco Animal Health has 496.65M shares outstanding. The number of shares has increased by 0.47% in one year.

Shares Outstanding	496.65M
Shares Change (YoY)	0.47%
Shares Change (QoQ)	0.41%
Owned by Institutions (%)	99.79%
Shares Floating	492.11M
Failed to Deliver (FTD) Shares	11
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 23.57M, so 4.75% of the outstanding shares have been sold short.

Short Interest	23.57M
Short % of Shares Out	4.75%
Short % of Float	6.56%
Short Ratio (days to cover)	5.51

Valuation Ratios

The PE ratio is 17.7 and the forward PE ratio is 17.47. Elanco Animal Health's PEG ratio is -0.14.

PE Ratio	17.7
Forward PE	17.47
PS Ratio	1.35
Forward PS	1.8
PB Ratio	0.98
P/FCF Ratio	15.18
PEG Ratio	-0.14

Financial Ratio History

Enterprise Valuation

Elanco Animal Health has an Enterprise Value (EV) of 9.84B.

EV / Sales	2.22
EV / EBITDA	7.1
EV / EBIT	18.18
EV / FCF	24.96

Financial Position

The company has a current ratio of 2.44, with a Debt / Equity ratio of 0.71.

Current Ratio	2.44
Quick Ratio	1.25
Debt / Equity	0.71
Debt / EBITDA	3.12
Debt / FCF	10.97
Interest Coverage	1.07

Financial Efficiency

Return on Equity is 5.54% and Return on Invested Capital is 1.53%.

Return on Equity	5.54%
Return on Assets	2.68%
Return on Invested Capital	1.53%
Revenue Per Employee	$493.22K
Profits Per Employee	$37.56K
Employee Count	9,000
Asset Turnover	0.35
Inventory Turnover	1.61

Taxes

Income Tax	150M
Effective Tax Rate	30.74%

Stock Price Statistics

The stock price has increased by 30.71% in the last 52 weeks. The beta is 1.66, so Elanco Animal Health's price volatility has been higher than the market average.

Beta	1.66
52-Week Price Change	30.71%
50-Day Moving Average	14.29
200-Day Moving Average	12.27
Relative Strength Index (RSI)	71.83
Average Volume (20 Days)	5,635,754

Income Statement

In the last 12 months, Elanco Animal Health had revenue of 4.44B and earned 338M in profits. Earnings per share was 0.68.

Revenue	4.44B
Gross Profit	1.91B
Operating Income	251M
Net Income	338M
EBITDA	1.39B
EBIT	723M
Earnings Per Share (EPS)	0.68

Full Income Statement

Balance Sheet

The company has 468M in cash and 4.32B in debt, giving a net cash position of -3.85B.

Cash & Cash Equivalents	468M
Total Debt	4.32B
Net Cash	-3.85B
Retained Earnings	-1.95B
Total Assets	13.74B
Working Capital	2.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 541M and capital expenditures -147M, giving a free cash flow of 394M.

Operating Cash Flow	541M
Capital Expenditures	-147M
Free Cash Flow	394M
FCF Per Share	0.8

Full Cash Flow Statement

Margins

Gross margin is 43.01%, with operating and profit margins of 5.65% and 7.61%.

Gross Margin	43.01%
Operating Margin	5.65%
Pretax Margin	10.99%
Profit Margin	7.61%
EBITDA Margin	31.2%
EBIT Margin	5.65%
FCF Margin	8.88%

Dividends & Yields

ELAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	5.65%
FCF Yield	6.59%

Dividend Details

Analyst Forecast

The average price target for ELAN is $18, which is 5.2% higher than the current price. The consensus rating is "Buy".

Price Target	$18
Price Target Difference	5.2%
Analyst Consensus	Buy
Analyst Count	7

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	13.78
Graham Upside	-19.46%

Scores

Altman Z-Score	1.26
Piotroski F-Score	7